Skip to main content
Fig. 9 | Journal of Experimental & Clinical Cancer Research

Fig. 9

From: Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway

Fig. 9

BD suppresses the orthotopic PDAC tumor growth and sensitizes the efficacy to GEM by inhibiting Nrf2 pathway. a Schematic presentation of the experiments on orthotopic PDAC murine model. b The body weight of mice was measured every 4 days after injection of cells. c-d Representative images of tumor and the tumor weight (n = 6–7). e Representative image of H&E and IHC staining of the resected tumors (Scale bar: 50 μm). f Statistical graphs of the IHC staining of Ki67 and Nrf2. g Schematic diagram of the regulation of Nrf2 signaling by BD treatment in PDAC cells. Data were presented as the mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with the control group; n.s., no significant. ##p < 0.01 and ###p < 0.001 compared with the GEM group

Back to article page